In summary, based on the multivariate cox regression analysis of the BC cohort, the constructed KLF11-related prognostic models for DFS and DMFS have a high accuracy in predicting the 3-,5- and 10 -year survival probability of BC patients. This evidence concerns the gene KLF11 and breast cancer.